Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
H1 2023 revenue at €11.4M, an increase from H2 2022 revenue (€11.1M).Order backlog at €64.6M as at June 30, 2023, +€2.6M compared to March 31, 2023, +€3.8M compared to December 31, 2022.Onboarding of academic sites involved in the pivotal validation plan in progress for the iBiopsy® LCS CADe/CADx software as medical.
Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Further double-digit growth for the Company in 2022: revenue up 16% compared with 2021 (€23.7 million vs. €20.5 million).Revenue of €5.6 million and order backlog at €62 million in Q1 2023.Cash and cash equivalents of €13.1 million at March 31, 2023.Company financing horizon confirmed for December 2023.Advanced disc.
Further to the Q-submission phase completion, Median’s iBiopsy LCS CADe/CADx SaMD pivotal study protocols are now finalized and ready for study execution.